Researchers find priority targets for ovarian cancer immunotherapy

[News]

Researchers at Roswell Park Cancer Institute (RPCI) have found that the expression pattern of a unique class of tumor-associated antigens, known as the MAGE cancer-testis antigens (CTAs), correlates with clinical outcome in epithelial ovarian cancer.

More... (http://www.news-medical.net/news/20140814/Researchers-find-priority-targets-for-ovarian-cancer-immunotherapy.aspx)